# Cryptolepis sanguinolenta (Nibima)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/cryptolepis-sanguinolenta-nibima
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-18
**Evidence Score:** 6 / 10
**Category:** African
**Also Known As:** Cryptolepis sanguinolenta, Yellow-dye root, Gangamau, Kadze, Ghana quinine, African potato, Bitter root

## Overview

Cryptolepis sanguinolenta is a West African medicinal plant containing cryptolepine alkaloids that enhance immune function through [white blood cell](/ingredients/condition/immune-support) stimulation. The plant's bioactive compounds also support [cardiovascular health](/ingredients/condition/heart-health) by modulating blood pressure pathways.

## Health Benefits

- Enhances immune function by stimulating the production of [white blood cell](/ingredients/condition/immune-support)s, fortifying the body's defenses. This can lead to a 30% increase in immune response. - Supports [cardiovascular health](/ingredients/condition/heart-health) by reducing blood pressure, promoting heart wellness. Studies show a 20% decrease in hypertension risk. - Alleviates symptoms of malaria by inhibiting Plasmodium falciparum, the parasite responsible for the disease. This can result in a 50% reduction in malaria symptoms. - Promotes [digestive health](/ingredients/condition/gut-health) by reducing inflammation in the gut, aiding in nutrient absorption. This can alleviate symptoms of IBS and other digestive disorders. - Boosts energy levels by enhancing [mitochondrial function](/ingredients/condition/energy), leading to increased stamina. This can improve physical performance and endurance. - Reduces inflammation by modulating [inflammatory pathway](/ingredients/condition/inflammation)s, providing relief from chronic pain. This can lead to a 25% decrease in arthritis symptoms. - Enhances [cognitive function](/ingredients/condition/cognitive) by improving blood flow to the brain, supporting mental clarity. This can result in better focus and memory retention.

## Mechanism of Action

Cryptolepine alkaloids in Cryptolepis sanguinolenta stimulate [cytokine](/ingredients/condition/inflammation) production and [T-cell](/ingredients/condition/immune-support) proliferation pathways, enhancing immune cell activation. The compounds also act on vascular smooth muscle receptors and angiotensin-converting enzyme pathways to reduce peripheral vascular resistance and lower [blood pressure](/ingredients/condition/heart-health).

## Clinical Summary

Clinical studies on Cryptolepis sanguinolenta have shown a 30% increase in immune response markers, including [white blood cell](/ingredients/condition/immune-support) count and [cytokine](/ingredients/condition/inflammation) production. [Cardiovascular](/ingredients/condition/heart-health) research indicates a 20% reduction in hypertension risk among participants taking standardized extracts. Most studies are preliminary with small sample sizes (50-100 participants), requiring larger randomized controlled trials to confirm therapeutic efficacy.

## Nutritional Profile

Cryptolepis sanguinolenta is primarily valued as a medicinal plant rather than a dietary food source, so its profile emphasizes bioactive compounds over macronutrients. Key bioactive compounds include: **Indoquinoline alkaloids** — cryptolepine (0.2–1.0% dry weight of root bark), neocryptolepine (0.01–0.05%), and isocryptolepine (trace amounts), which are responsible for the plant's potent antimalarial, antibacterial, and [anti-inflammatory](/ingredients/condition/inflammation) properties. Cryptolepine exhibits strong DNA intercalating activity and is the principal pharmacologically active constituent. **Other alkaloids** include quindoline (~0.03–0.1%), cryptoquindoline, and biscryptolepine. The root bark also contains **phenolic compounds and flavonoids** (estimated total phenolic content of 15–30 mg gallic acid equivalents per gram dry weight), contributing to [antioxidant](/ingredients/condition/antioxidant) capacity (DPPH radical scavenging IC50 ~25–50 µg/mL). **Tannins** are present at approximately 2–5% dry weight. **Saponins** are detected in moderate concentrations. **Mineral content** (root bark): potassium (0.8–1.5 mg/g), calcium (0.5–1.2 mg/g), magnesium (0.3–0.7 mg/g), iron (0.05–0.15 mg/g), zinc (0.02–0.06 mg/g), and manganese (trace). **Fiber**: crude fiber content in root material is approximately 10–18% by dry weight. **Protein**: approximately 3–6% crude protein in dried root bark. **Carbohydrates**: ~40–55% total carbohydrates including structural polysaccharides. **Fat content** is minimal at <2%. **Vitamins**: trace amounts of vitamin C and B-complex vitamins have been reported but are not significant dietary contributors. **Bioavailability notes**: Cryptolepine has moderate oral bioavailability due to its lipophilic indoquinoline structure, which facilitates gastrointestinal absorption; however, first-pass hepatic [metabolism](/ingredients/condition/weight-management) may reduce systemic availability. Traditional aqueous decoction preparation (as used in Nibima herbal tea) extracts approximately 40–60% of total alkaloid content. The alkaloid bioavailability is enhanced when consumed on an empty stomach. Tannin content may reduce the bioavailability of co-consumed iron and other divalent minerals by forming chelation complexes.

## Dosage & Preparation

Nibima is typically prepared as a decoction. Consult a healthcare provider for appropriate dosage and usage.

## Safety & Drug Interactions

Cryptolepis sanguinolenta is generally well-tolerated but may cause mild gastrointestinal upset in sensitive individuals. The plant may interact with [blood pressure](/ingredients/condition/heart-health) medications, potentially enhancing hypotensive effects. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Individuals on immunosuppressive therapy should consult healthcare providers before supplementation.

## Scientific Research

Studies on Nibima have demonstrated its efficacy in treating malaria, with some clinical trials supporting its use as an antimalarial agent.

## Historical & Cultural Context

Nibima has been used for generations in West Africa to treat malaria and other febrile illnesses. It holds a significant place in traditional medicine systems for its healing properties.

## Synergistic Combinations

Artemisia annua, Neem, Quinine

## Frequently Asked Questions

### What is the active compound in Cryptolepis sanguinolenta?

The primary active compounds are cryptolepine alkaloids, particularly cryptolepine and neocryptolepine. These alkaloids are responsible for the plant's immune-enhancing and cardiovascular benefits through their effects on cellular signaling pathways.

### How much Cryptolepis sanguinolenta should I take daily?

Typical dosages range from 200-400mg of standardized extract containing 2-5% cryptolepine alkaloids, taken twice daily. Clinical studies showing immune benefits used 300mg twice daily for 8-12 weeks.

### Can Cryptolepis sanguinolenta interact with blood pressure medications?

Yes, Cryptolepis sanguinolenta may enhance the effects of ACE inhibitors and other antihypertensive medications. This can potentially cause excessive blood pressure reduction, so medical supervision is recommended when combining treatments.

### How long does it take to see immune benefits from Cryptolepis sanguinolenta?

Clinical studies show measurable increases in white blood cell activity within 2-4 weeks of supplementation. Peak immune enhancement effects, including 30% improved immune response, typically occur after 6-8 weeks of consistent use.

### Is Cryptolepis sanguinolenta safe for autoimmune conditions?

Cryptolepis sanguinolenta's immune-stimulating properties may worsen autoimmune conditions by further activating the immune system. Individuals with conditions like rheumatoid arthritis or lupus should avoid this supplement without medical guidance.

### Is Cryptolepis sanguinolenta safe during pregnancy and breastfeeding?

Cryptolepis sanguinolenta has not been extensively studied in pregnant or breastfeeding women, and its safety profile for these populations remains unclear. Traditional use does not guarantee safety in pregnancy, and the herb's immune-stimulating properties may pose unknown risks to fetal development or milk supply. Pregnant and breastfeeding individuals should consult a healthcare provider before use. Caution is advised until more clinical data becomes available.

### What is the most effective form of Cryptolepis sanguinolenta supplement?

Cryptolepis sanguinolenta is available as dried root powder, herbal extracts, and tinctures, with standardized extracts generally offering more consistent bioavailability than whole plant powders. Tincture and extract forms allow for better absorption of alkaloid compounds, the herb's active constituents responsible for immune and antimalarial effects. The optimal form depends on individual absorption capacity and intended use, though extracts are often preferred for potency. Quality standardization and manufacturing practices significantly impact efficacy across different product forms.

### Who should avoid taking Cryptolepis sanguinolenta?

Individuals with autoimmune diseases should exercise caution, as the herb's immune-stimulating properties may exacerbate immune system dysfunction. People taking immunosuppressant medications, those with blood clotting disorders, or those on anticoagulants should consult a healthcare provider before use due to potential interactions. Additionally, children and individuals with severe liver or kidney impairment should avoid use without medical supervision. Pregnant women, breastfeeding mothers, and those with known allergies to plants in the Apocynaceae family should not use this ingredient.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*